Reverse Payment Suit Over Generic K-Dur Tossed

Law360, New York (March 25, 2010, 4:50 PM ET) -- A federal judge has thrown out a reverse payment antitrust class action that accused Schering-Plough Corp., now a part of Merck & Co., and Upsher-Smith Laboratories Inc. of conspiring to keep generic versions of the potassium supplement K-Dur 20 off the market.

Judge Joseph A. Greenaway Jr. of the U.S. District Court for the District of New Jersey on Thursday adopted a February 2009 report by special master Stephen Orlofsky that recommended Schering-Plough and Upsher-Smith's motions for summary judgment be granted, and that the direct purchaser...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required